Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NYSE MKT LLC:MDGN)

3.38
Delayed Data
As of Feb 12
 +0.13 / +4.00%
Today’s Change
3.09
Today|||52-Week Range
10.25
-43.85%
Year-to-Date
No recent news for Medgenics Inc.

Today’s Trading

Previous close3.25
Today’s open3.27
Day’s range3.25 - 3.51
Volume131,931
Average volume (3 months)161,701
Market cap$111.1M
Dividend yield--
Data as of 4:02pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+5.66%
Earnings growth (this year)-32.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...+0.15+1.74%
DRNADicerna Pharmaceutic...+0.21+4.02%
CORICorium International...+0.24+5.11%
ANTHAnthera Pharmaceutic...+0.19+7.12%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$18.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Chief Financial Officer &
Head-Investor Relations
Brian Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts

Partner Offers